NASDAQ: STOK Stoke Therapeutics, Inc. 8-K

Stoke Therapeutics reports Q1 2026 financial results

Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read

1 material change detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade STOK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 5, 2026 4:37 PM